CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 11, 2006--Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company developing and commercializing oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, announced today that John M. Sorvillo, Ph.D. has been appointed Vice President of Business Development. In this position, Dr. Sorvillo will be responsible for establishing partnerships for Altus’ late stage products and seeking development collaborations for its early stage and preclinical programs.
